Stoke Therapeutics (STOK) Revenue (2022 - 2026)
Stoke Therapeutics (STOK) recorded Revenue of $9.33 million in Q2 2026, down 32.5% from $13.82 million a year earlier but up 49.7% from the prior quarter.
Stoke Therapeutics (STOK) Revenue (2022 - 2026) Analysis & Trends
On a TTM basis, Stoke Therapeutics' Revenue came in at $27.59 million as of Jun 30, 2026, down 86.2% year-over-year; for FY2025, it was $184.42 million, up 404.5% from FY2024.
- Annual Revenue has a three-year compound annual growth rate of 145.9% (FY2022 to FY2025).
- Across earlier years, Revenue came in at $36.56 million in FY2024 (+316.3%), $8.78 million in FY2023 (-29.2%) and $12.41 million in FY2022.
- Quarterly Revenue has ranged from $1.4 million in Q4 2025 to $158.57 million in Q1 2025 over the past five years.
- On a year-over-year basis, Revenue has declined for three consecutive quarters, with growth averaging 119.4% over the last seven quarters.
- Peak year-over-year performance for Revenue in the last five years was growth of 707.1% in Q4 2024, against a decline of 96.1% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.23 million (Q1 2026), $1.4 million (Q4 2025) and $10.63 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Stoke Therapeutics | 1.60 Bn | 429.41 Mn | - | 9.33 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.33 Mn |
| Mar 31, 2026 | 6.23 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 10.63 Mn |
| Jun 30, 2025 | 13.82 Mn |
| Mar 31, 2025 | 158.57 Mn |
| Dec 31, 2024 | 22.61 Mn |
| Sep 30, 2024 | 4.89 Mn |
| Jun 30, 2024 | 4.83 Mn |
| Mar 31, 2024 | 4.22 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Sep 30, 2023 | 3.31 Mn |
| Jun 30, 2023 | 2.48 Mn |
| Mar 31, 2023 | 5.15 Mn |
| Dec 31, 2022 | 3.27 Mn |
| Sep 30, 2022 | 2.91 Mn |
| Jun 30, 2022 | 3.23 Mn |
| Mar 31, 2022 | 3.00 Mn |
Stoke Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=STOK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "STOK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=STOK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();